Physician profile
John Walsh
NPI 1245222736
$1,665.43
in general payments reported to CMS, 2019-2025
13 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $32.51 · 2021: $72.08 · 2022: $82.69 · 2023: $239 · 2024: $546 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Education: $10.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.63 |
| Education | $10.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $608.42 | 2019-2025 | Ofev |
| Glaxosmithkline, LLC. | $305.48 | 2019-2024 | Nucala, Trelegy Ellipta |
| Genentech USA, INC. | $245.12 | 2019 | |
| Ceribell, INC. | $151.51 | 2024 | Pocket Eeg Device |
| Grifols USA, LLC | $83.87 | 2022-2024 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $65.44 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $42.70 | 2019 | |
| Merck Sharp & Dohme LLC | $38.96 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $33.66 | 2019-2022 | |
| Vapotherm INC | $32.21 | 2022 | |
| Baxter Healthcare | $26.95 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Medical Device Business Services, INC. | $20.13 | 2021 | |
| Pfizer INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.